Table 2 Demographic, laboratory and pathology data for the patient cohort.
Variable | Reversible (N = 21) | Irreversible (N = 36) | p value |
|---|---|---|---|
N (%) or median (range) | |||
Age (years) | 29 (21–60) | 48 (23–67) | 0.0045 |
Female | 8 (38.10%) | 20 (55.56%) | |
Male | 13 (61.90%) | 16 (44.44%) | |
ALT | 54 (20–152) | 52 (4–228) | 0.7442 |
AST | 35 (24–95) | 43 (16–143) | 0.4125 |
ALB | 45 (37–51) | 45 (39–53) | 0.6891 |
TBIL | 10 (6–29) | 11.5 (6.7–38) | 0.5577 |
INR | 1 (0.9–1.22) | 1 (0.8–1.56) | 0.8354 |
PLT | 213 (109–298) | 164.5 (42–299) | 0.0254 |
Fibrosis stage (Ishak) | |||
0 | 0 (0%) | 2 (5.56%) | |
1 | 3 (14.29%) | 2 (5.56%) | |
2 | 2 (9.52%) | 2 (5.56%) | |
3 | 3 (14.29%) | 8 (22.22%) | |
4 | 8 (38.10%) | 8 (22.22%) | |
5 | 1 (4.76%) | 3 (8.33%) | |
6 | 4 (19.05%) | 11 (30.56%) | |
